Women using a progesterone-releasing IUD for birth control had significantly fewer unintended pregnancies, including ectopics, compared to those using a copper IUD
GLP-1 agonists such as Ozempic should generally be avoided in individuals with: A personal or family history of medullary thyroid carcinoma Multiple Endocrine Neoplasia syndrome type 2 (MEN2) A prior history of pancreatitis Progressive diabetic retinopathy, particularly in those with long-standing or poorly controlled diabetes Congestive heart failure, where fluid balance, heart rate, and medication interactions require close monitoring (35) A thorough medical history and medication review are essential before initiating therapy to determine whether GLP-1 agonists are appropriate or contraindicated
The titration schedule might also vary depending on your primary concern
I will also try to break down the pros and cons, as I see them, of these new treatments
Orforglipron (Not Yet FDA Approved) According to CNN, Eli Lilly's oral GLP-1 candidate achieved approximately 11 percent average weight loss over 72 weeks at the highest dose